Kyoya Kumagai

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7

Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan

Kyoya Kumagai, Toshiyuki Takagi, Shinobu Nakamura et al. · Annals of Oncology · 1997 · 123 citations · Full text

Hepatitis D, Lymphoid Neoplasia, Hepatology +9

A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma

Yasuhito Terui, Shinya Rai, Koji Izutsu et al. · Cancer Science · 2021 · 51 citations · Full text

Bacillus cereus Brain Abscesses Occurring in a Severely Neutropenic Patient: Successful Treatment with Antimicrobial Agents, Granulocyte Colony-Stimulating Factor and Surgical Drainage.

Chikara Sakai, Toshihiko Iuchi, Akihiro Ishii et al. · Internal Medicine · 2001 · 32 citations · Full text

Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation

Hideki Tsujimura, Toshiko Miyaki, Shuhei Yamada et al. · International Journal of Hematology · 2014 · 28 citations

Surgical Oncology, Malignant Disease, Medicine +8